Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab
Gespeichert in:
Veröffentlicht in: | Rheumatology (Oxford, England) England), 2020-01, Vol.59 (1), p.252-254 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 254 |
---|---|
container_issue | 1 |
container_start_page | 252 |
container_title | Rheumatology (Oxford, England) |
container_volume | 59 |
creator | Sakumura, Naoto Irabu, Hitoshi Inoue, Natsumi Mizuta, Mao Shimizu, Masaki |
description | |
doi_str_mv | 10.1093/rheumatology/kez245 |
format | Article |
fullrecord | <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_rheumatology_kez245</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/rheumatology/kez245</oup_id><sourcerecordid>10.1093/rheumatology/kez245</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-4b98b0e783bc28cfe557997f8c4e784e7a5f4adf42213a3834a1d82f4667f08f3</originalsourceid><addsrcrecordid>eNqNkF1LwzAUhoMobk5_gSD5A93y1Ta9lOHHYODNvC5pmmxxbVKSVNl-vR3V4aUXh3M4531fDg8A9xjNMSrowu9U34roGrc9LPbqSFh6AaaYZSRBlJLL80zYBNyE8IEQSjHl12BCMeGIIjQF7bIx1kjRwD4o3TdWhQCdho2zWxP72tjhtFonGWydNdF5Y7fQWChgJ6JRNsIvE3dwI_biIEIPhfPRRBOgV1KZz5M6Omkacxx-rW7BlRZNUHc_fQben582y9dk_fayWj6uE0nTLCasKniFVM5pJQmXWqVpXhS55pINy6FEqpmoNSMEU0E5ZQLXnGiWZblGXNMZoGOu9C4Er3TZedMKfygxKk_wyr_wyhHe4HoYXV1ftao-e35pDYL5KHB996_Ebx_Sgsk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Sakumura, Naoto ; Irabu, Hitoshi ; Inoue, Natsumi ; Mizuta, Mao ; Shimizu, Masaki</creator><creatorcontrib>Sakumura, Naoto ; Irabu, Hitoshi ; Inoue, Natsumi ; Mizuta, Mao ; Shimizu, Masaki</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kez245</identifier><identifier>PMID: 31280300</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Antibodies, Monoclonal, Humanized - therapeutic use ; Aorta, Thoracic - diagnostic imaging ; Aortitis - blood ; Aortitis - diagnosis ; Aortitis - drug therapy ; Biomarkers - blood ; Child ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Interleukin-6 - blood ; Monitoring, Physiologic - methods ; Positron Emission Tomography Computed Tomography ; Takayasu Arteritis - blood ; Takayasu Arteritis - diagnosis ; Takayasu Arteritis - drug therapy</subject><ispartof>Rheumatology (Oxford, England), 2020-01, Vol.59 (1), p.252-254</ispartof><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-4b98b0e783bc28cfe557997f8c4e784e7a5f4adf42213a3834a1d82f4667f08f3</citedby><cites>FETCH-LOGICAL-c356t-4b98b0e783bc28cfe557997f8c4e784e7a5f4adf42213a3834a1d82f4667f08f3</cites><orcidid>0000-0003-1077-7772</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31280300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakumura, Naoto</creatorcontrib><creatorcontrib>Irabu, Hitoshi</creatorcontrib><creatorcontrib>Inoue, Natsumi</creatorcontrib><creatorcontrib>Mizuta, Mao</creatorcontrib><creatorcontrib>Shimizu, Masaki</creatorcontrib><title>Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Aorta, Thoracic - diagnostic imaging</subject><subject>Aortitis - blood</subject><subject>Aortitis - diagnosis</subject><subject>Aortitis - drug therapy</subject><subject>Biomarkers - blood</subject><subject>Child</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Interleukin-6 - blood</subject><subject>Monitoring, Physiologic - methods</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Takayasu Arteritis - blood</subject><subject>Takayasu Arteritis - diagnosis</subject><subject>Takayasu Arteritis - drug therapy</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1LwzAUhoMobk5_gSD5A93y1Ta9lOHHYODNvC5pmmxxbVKSVNl-vR3V4aUXh3M4531fDg8A9xjNMSrowu9U34roGrc9LPbqSFh6AaaYZSRBlJLL80zYBNyE8IEQSjHl12BCMeGIIjQF7bIx1kjRwD4o3TdWhQCdho2zWxP72tjhtFonGWydNdF5Y7fQWChgJ6JRNsIvE3dwI_biIEIPhfPRRBOgV1KZz5M6Omkacxx-rW7BlRZNUHc_fQben582y9dk_fayWj6uE0nTLCasKniFVM5pJQmXWqVpXhS55pINy6FEqpmoNSMEU0E5ZQLXnGiWZblGXNMZoGOu9C4Er3TZedMKfygxKk_wyr_wyhHe4HoYXV1ftao-e35pDYL5KHB996_Ebx_Sgsk</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Sakumura, Naoto</creator><creator>Irabu, Hitoshi</creator><creator>Inoue, Natsumi</creator><creator>Mizuta, Mao</creator><creator>Shimizu, Masaki</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-1077-7772</orcidid></search><sort><creationdate>20200101</creationdate><title>Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab</title><author>Sakumura, Naoto ; Irabu, Hitoshi ; Inoue, Natsumi ; Mizuta, Mao ; Shimizu, Masaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-4b98b0e783bc28cfe557997f8c4e784e7a5f4adf42213a3834a1d82f4667f08f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Aorta, Thoracic - diagnostic imaging</topic><topic>Aortitis - blood</topic><topic>Aortitis - diagnosis</topic><topic>Aortitis - drug therapy</topic><topic>Biomarkers - blood</topic><topic>Child</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Interleukin-6 - blood</topic><topic>Monitoring, Physiologic - methods</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Takayasu Arteritis - blood</topic><topic>Takayasu Arteritis - diagnosis</topic><topic>Takayasu Arteritis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakumura, Naoto</creatorcontrib><creatorcontrib>Irabu, Hitoshi</creatorcontrib><creatorcontrib>Inoue, Natsumi</creatorcontrib><creatorcontrib>Mizuta, Mao</creatorcontrib><creatorcontrib>Shimizu, Masaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakumura, Naoto</au><au>Irabu, Hitoshi</au><au>Inoue, Natsumi</au><au>Mizuta, Mao</au><au>Shimizu, Masaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>59</volume><issue>1</issue><spage>252</spage><epage>254</epage><pages>252-254</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>31280300</pmid><doi>10.1093/rheumatology/kez245</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-1077-7772</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-0324 |
ispartof | Rheumatology (Oxford, England), 2020-01, Vol.59 (1), p.252-254 |
issn | 1462-0324 1462-0332 |
language | eng |
recordid | cdi_crossref_primary_10_1093_rheumatology_kez245 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection |
subjects | Antibodies, Monoclonal, Humanized - therapeutic use Aorta, Thoracic - diagnostic imaging Aortitis - blood Aortitis - diagnosis Aortitis - drug therapy Biomarkers - blood Child Disease Progression Female Follow-Up Studies Humans Interleukin-6 - blood Monitoring, Physiologic - methods Positron Emission Tomography Computed Tomography Takayasu Arteritis - blood Takayasu Arteritis - diagnosis Takayasu Arteritis - drug therapy |
title | Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A57%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20usefulness%20of%20longitudinal%20IL-6%20monitoring%20in%20a%20patient%20with%20Takayasu%20aortitis%20receiving%20tocilizumab&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Sakumura,%20Naoto&rft.date=2020-01-01&rft.volume=59&rft.issue=1&rft.spage=252&rft.epage=254&rft.pages=252-254&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kez245&rft_dat=%3Coup_cross%3E10.1093/rheumatology/kez245%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31280300&rft_oup_id=10.1093/rheumatology/kez245&rfr_iscdi=true |